- The Infrastructure of Understanding Antifungal Chemotherapy.
- History of Antifungals.
- Epidemiology of fungal infections: What, Where, When.
- In vitro antifungal susceptibility: What it can and cannot do.
- Animal models: Use and value in antifungal development and therapeutic strategies.
- Antifungal pharmacokinetics and pharmacogenomics: Principles and Practices.
- Antifungal Drug Resistance: Mechanisms and Importance.
- Antifungal Drugs.
- Allylamines/Griseofulvin.
- Azoles.
- Candins.
- Polyenes.
- Pyrimidines.
- Immunomodulators: What is the evidence for use in mycoses?
- Combination Antifungals: The good, bad, and ugly.
- Clinical management.
- Antifungal prophylaxis: Ounce of Prevention Worth a Pound of Cure.
- Empirical antifungal therapy: From neutropenics to ICUs.
- Pre-emptive antifungal therapy: Do diagnostics help?
- Host immune response to fungal infections: Implications for immunotherapy
- Use of topical antifungals and alternative methods of antifungal drug delivery.
- Biofilms and catheters: With fungi what are the issues and solutions.
- Antifungal Pharmacoeconomics: Is cost a factor?
- Sick Building Syndrome and yeast connection: Where are the data?
- Aspergillosis.
- Candidiasis.
- Specific managements.
- Cryptococcosis.
- Dermatophytosis.
- Endemic mycoses.
- Hyalohyphomycosis.
- Phaeohyphomycosis.
- Pneumocystosis.
- Zygomycosis.
- Risk group management for fungal infections.
- Transplant recipients: from bone marrow to solid organ transplants.
- Transplant recipients: Hematopoietic stem cell transplant patient and acute leukemia patient.
- Neonates: yeasts are beasts in early life.
- Pediatric fungal management: Children are not little adults.
- Mycoses in HIV-infected patients in the era of HAART.
- Burn victims and mycoses.
- Allergic Bronchopulmonary Aspergillosis/Allergic Fungal Sinusitis: too much of a good thing?
- Sites of infection.
- CNS fungal infections.
- Fungal osteomyelitis.
- Fungal endocarditis.
- Fungal infections of the urinary tract.
- Fungal keratitis/endophthalmitis.
- Intra-abdominal fungal infections.
- Fungal pneumonias.
- Mahmoud A. Ghannoum, University Hospital of Cleveland, Cleveland, OH, USA
- John R. Perfect, Duke University, Durham, NC, USA
"Antifungal Therapy is a valuable ressource for experienced clinicians and pharmacists, as well as for knowledgeable scientists with an avid interest in the treatment of mycoses. Each of the 30 chapters presents convincing detailed evidence in its treatment recommendations for the gamut of infections spanning dermatophytosis to invasive mycoses."
Clinical Infectious Diseases, August 2010
